Tenable Holdings Valuation
Is TENB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TENB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TENB * (MX$766.6) is trading below our estimate of fair value (MX$1061.05)
Significantly Below Fair Value: TENB * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TENB *?
Other financial metrics that can be useful for relative valuation.
| What is TENB *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$5.23b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 6.2x |
| Enterprise Value/EBITDA | 2085.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does TENB *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10.5x | ||
500408 Tata Elxsi | 12.8x | 11.2% | ₹455.3b |
VRNS Varonis Systems | 9.7x | 11.0% | US$4.9b |
RBRK Rubrik | 10.1x | 20.1% | US$6.4b |
QLYS Qualys | 9.5x | 8.6% | US$5.4b |
TENB * Tenable Holdings | 6.3x | 12.8% | Mex$5.2b |
Price-To-Sales vs Peers: TENB * is good value based on its Price-To-Sales Ratio (6.3x) compared to the peer average (10.5x).
Price to Earnings Ratio vs Industry
How does TENB *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: TENB * is expensive based on its Price-To-Sales Ratio (6.3x) compared to the Global Software industry average (3x).
Price to Sales Ratio vs Fair Ratio
What is TENB *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 6.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate TENB *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$766.60 | Mex$971.31 +26.7% | 9.5% | Mex$1,094.83 | Mex$724.27 | n/a | 18 |
| May ’25 | n/a | Mex$1,003.14 0% | 9.2% | Mex$1,118.72 | Mex$740.08 | n/a | 19 |
| Apr ’25 | n/a | Mex$999.29 0% | 8.7% | Mex$1,111.38 | Mex$735.22 | n/a | 18 |
| Mar ’25 | n/a | Mex$999.29 0% | 8.7% | Mex$1,111.38 | Mex$735.22 | n/a | 18 |
| Feb ’25 | n/a | Mex$909.34 0% | 11.3% | Mex$1,118.57 | Mex$636.72 | n/a | 19 |
| Jan ’25 | n/a | Mex$862.43 0% | 10.6% | Mex$978.57 | Mex$635.21 | n/a | 17 |
| Dec ’24 | Mex$721.03 | Mex$858.91 +19.1% | 11.0% | Mex$989.05 | Mex$642.02 | n/a | 16 |
| Nov ’24 | Mex$750.00 | Mex$977.30 +30.3% | 7.4% | Mex$1,122.17 | Mex$837.18 | n/a | 15 |
| Oct ’24 | Mex$790.31 | Mex$947.29 +19.9% | 7.1% | Mex$1,078.94 | Mex$822.05 | n/a | 16 |
| Sep ’24 | n/a | Mex$921.57 0% | 7.0% | Mex$1,009.02 | Mex$807.22 | n/a | 15 |
| Aug ’24 | n/a | Mex$910.60 0% | 6.3% | Mex$1,010.44 | Mex$808.35 | n/a | 14 |
| Jul ’24 | n/a | Mex$865.90 0% | 8.0% | Mex$995.36 | Mex$760.10 | n/a | 13 |
| Jun ’24 | n/a | Mex$865.90 0% | 8.0% | Mex$995.36 | Mex$760.10 | n/a | 13 |
| May ’24 | n/a | Mex$865.90 0% | 8.0% | Mex$995.36 | Mex$760.10 | n/a | 13 |
| Apr ’24 | n/a | Mex$956.57 0% | 8.6% | Mex$1,171.46 | Mex$847.05 | n/a | 13 |
| Mar ’24 | n/a | Mex$1,000.97 0% | 8.5% | Mex$1,230.92 | Mex$890.05 | n/a | 14 |
| Feb ’24 | Mex$755.62 | Mex$914.58 +21.0% | 9.7% | Mex$1,129.77 | Mex$790.84 | n/a | 14 |
| Jan ’24 | Mex$706.03 | Mex$959.32 +35.9% | 12.3% | Mex$1,190.30 | Mex$734.02 | n/a | 14 |
| Dec ’23 | n/a | Mex$959.32 0% | 12.3% | Mex$1,190.30 | Mex$734.02 | Mex$721.03 | 14 |
| Nov ’23 | Mex$793.67 | Mex$959.32 +20.9% | 12.3% | Mex$1,190.30 | Mex$734.02 | Mex$750.00 | 14 |
| Oct ’23 | n/a | Mex$1,095.17 0% | 10.2% | Mex$1,292.62 | Mex$894.89 | Mex$790.31 | 14 |
| Sep ’23 | n/a | Mex$1,095.17 0% | 10.2% | Mex$1,292.62 | Mex$894.89 | n/a | 14 |
| Aug ’23 | n/a | Mex$1,129.36 0% | 10.2% | Mex$1,323.47 | Mex$916.25 | n/a | 15 |
| Jul ’23 | Mex$914.26 | Mex$1,386.16 +51.6% | 6.8% | Mex$1,558.92 | Mex$1,194.50 | n/a | 15 |
| Jun ’23 | Mex$990.61 | Mex$1,342.04 +35.5% | 6.8% | Mex$1,515.48 | Mex$1,161.21 | n/a | 16 |
| May ’23 | n/a | Mex$1,404.17 0% | 6.4% | Mex$1,570.98 | Mex$1,285.35 | n/a | 17 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.